Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

PLoS ONE

Home Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

Correction: A compound downregulation of <i>SRRM2</i> and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

Soudabeh Fazeli, Majid Motovali-Bashi, Maryam Peymani, Motahare-Sadat Hashemi, Masoud Etemadifar, Mohammad Hossein Nasr-Esfahani, Kamran Ghaedi

https://doi.org/10.1371/journal.pone.0244776, Volume: 15, Issue: 12, Pages: 1-1

Article Type: Correction Article History

Publisher: Public Library of Science

Altmetric

Table of Contents

Fazeli,Motovali-Bashi,Peymani,Hashemi,Etemadifar,Hossein Nasr-Esfahani,and Ghaedi: Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease

There is an error in affiliation 2 for author Maryam Peymani. The correct affiliation 2 is: Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

Reference

SFazeli, MMotovali-Bashi, MPeymani, SHashemi M-, MEtemadifar, MHNasr-Esfahani, et al (2020) A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease. PLoS ONE 15(11): e0240855 10.1371/journal.pone.0240855